Immunoaffinity Chromatography

  • Paul Cutler
Part of the Methods in Molecular Biology book series (MIMB, volume 244)


The principle of immunoaffinity or immunoadsorption chromatography is based on the highly specific interaction of an antigen with its antibody (1). Immunoaffinity chromatography is a specialized form of affinity chromatography and, as such, utilizes an antibody or antibody fragment as a ligand immobilized onto a solid support matrix in a manner that retains its binding capacity. Although the technique includes the separation of antibodies using immobilized antigens (2, 3, 4), it is more commonly performed for the identification, quantification, or purification of antigens (see Note 1 and refs. 5 and 6). The crude extract is pumped through the column and the unbound material washed clear prior to elution of the retained antigen by alterations to the mobile-phase conditions that weaken the antibody-antigen interaction.


Storage Buffer Cyanogen Bromide Elution Condition Cyanate Ester Immunoaffinity Chromatography 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Phillips, T. M. (1989). High-performance immunoaffinity chromatography. Adv. Chromatogr. 29, 133–173.PubMedGoogle Scholar
  2. 2.
    Weliky, N., Weetall, H. H., Gilden, R. V., and Campbell, D. H. (1964) Synthesis and use of some insoluble immunologically specific adsorbents. Immunochemistry 1, 219–229.PubMedCrossRefGoogle Scholar
  3. 3.
    Kristiansen, T. (1976 ). Matrix-bound antigens and antibodies. Scand. J. Immunol. (Suppl.) 3, 19–27Google Scholar
  4. 4.
    Santucci, A., Soldani, D., Lozzi, L., et al. (1988) High performance liquid chromatography immunoaffinity purification of antibodies and antibody fragments. J. Immunol. Methods 114, 181–185.PubMedCrossRefGoogle Scholar
  5. 5.
    Muronetz, V. I., Sholukh, M., and Korpela, T. (2001) Use of protein-protein interactions in affinity chromatography. J. Biochem. Biophys. Methods 49, 29–47.PubMedCrossRefGoogle Scholar
  6. 6.
    Hage, D. S. (1998) Survey of recent advances in analytical applications of immunoaffinity chromatography. J. Chromatogr. 715, 3–28CrossRefGoogle Scholar
  7. 7.
    Hill, C. R., Kenney, A. C., and Goulding, L. (1987) The design, development and use of immunopurification reagents. Biotech. Forum 4, 168–171.Google Scholar
  8. 8.
    Dunbar, B. S. and Schwoebel, E. D. (1990) Preparation of polyclonal antibodies, in Methods in Enzymology (Deutscher, M. P., ed.), Academic, London, vol. 182, pp. 663–670.Google Scholar
  9. 9.
    Kohler, G. and Milstein, C. (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495–497PubMedCrossRefGoogle Scholar
  10. 10.
    Eliasson, M., Andersson, R., Olsson, A., Wigzell, H., and Uhlen, M. (1989) Differential IgG-binding characteristics of staphylococcal protein A, streptococcal protein G, and a chimeric protein AG. J. Biol. Chem. 142, 575–581.Google Scholar
  11. 11.
    Campbell, D. H., Luescher, E., and Lerman, L. S. (1951) Immunologic adsorbents. I. Isolation of antibody by means of a cellulose-protein antigen. Proc. Natl. Acad. Sci. USA 37, 575–578.PubMedCrossRefGoogle Scholar
  12. 12.
    Janatova, J. and Gobel, R. J. (1984) Rapid optimization of immunoadsorbent characteristics. Biochem. J. 221, 113–120.PubMedGoogle Scholar
  13. 13.
    Yarmush, M. L., Antonsen, K. P., Sundaram, S., and Yarmush, D. M. (1992) Immunoadsorption: strategies for antigen elution and production of reusable adsorbents. Biotechnol. Prog. 8, 168–178.PubMedCrossRefGoogle Scholar
  14. 14.
    Yan, S. B. (1996) Review of conformation-specific affinity purification methods for plasma vitamin K-dependent proteins. J. Mol. Recogn. 9, 211–218.CrossRefGoogle Scholar
  15. 15.
    Katz, S. E. and Brady, M. S. (1990) High-performance immunoaffinity chromatography for drug residue analysis. Anal. Chem. 73, 557–560.Google Scholar
  16. 16.
    Katz, S. E. and Siewierski, M. (1992) Drug residue analysis using immunoaffinity chromatography. J. Chromatogr. 624, 403–409.PubMedCrossRefGoogle Scholar
  17. 17.
    VanGinkel, L. A. (1991) Immunoaffinity chromatography, its applicability and limitations in multi-residue analysis of anabolizing and doping agents. J. Chromatogr. 564, 363–384.CrossRefGoogle Scholar
  18. 18.
    Jack, G. W. and Wade, H. E. (1987) Immunoaffinity chromatography of clinical products. TIBTECH 5, 91–95.Google Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2004

Authors and Affiliations

  • Paul Cutler
    • 1
  1. 1.Genomic and Proteomic Sciences, Medicines Research CenterGlaxoSmithKline PharmaceuticalsStevenageUK

Personalised recommendations